ANPEP and prostate cancer: APN was over-expressed in many tumors, such as breast, colon, gastric, ovarian, thyroid, and prostate cancers [63], and a selective APN inhibitor as a potential anti-cancer drug, a cyclic peptide named cyc-LHSPW, was identified [18].